QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Li, Wei;  Im, Seock-Ah;  Xu, Binghe;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 会议论文 CANCER RESEARCH, 2018-02-01 作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文 2018, 卷号: 78, 期号: 4 作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2016, 卷号: 17, 期号: 3 作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06 Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial 期刊论文 2016, 卷号: 17, 期号: 3, 页码: 357-366 作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1 会议论文 作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1 期刊论文 2015, 卷号: 75 作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13